The affect that food has on blood glucose levels in people with Type 1 diabetes is well established. Less clear, however, is the role that stress, time of day, activity levels and other factors play in regulating blood glucose. To better understand these dynamics, University at Buffalo researchers have launched a research project that combines artificial intelligence (AI) with data gathered by continuous glucose monitoring tools. Ultimately, the goal is to better understand the relationship between insulin and blood glucosen, empowering people with Type 1 diabetes to better manage the condition and improve their quality of life. "We're developing new tools -- combining data collected from diabetes monitoring tools with AI systems, as well as traditional time-series modeling approaches -- that could greatly improve how people manage their Type 1 diabetes," says the project's leader, Tarunraj Singh, PhD, professor of mechanical and aerospace engineering in the School of Engineering and Applied Sciences.
Invasive prick-and-test glucose monitoring may soon be history for diabetes patients. Sensory contact lenses may allow diabetes sufferers to measure their blood glucose levels without painful skin pricking. On-demand access to patients' glucose levels helps to reduce their risk of diabetes-related complications. Using the same technology that gives smartphones their vivid display, the lenses will be embedded with a sensor, which may be able to transmit vital health information to smartphones once they are fully developed. The scientists have already used the technology to measure kidney function and it may also be able to track drug use and detect early cancers in the future.
A single injection may soon give diabetics weeks of glucose control rather than having to self-administer as frequently as every day, new research reveals. Researchers discovered a new technology may improve on existing drugs that aim to better glucose control. By forming a gel that slowly dissolves under our body heat, the new therapy extends glucose control by up to three times in non-human primates, the study found. The researchers hope the treatment could last even longer in humans as we have a slower metabolism than most other animals and therefore break drugs down slower. Standard type 2 diabetes therapies have to be administered at least twice a day, while the longest-acting glucose control treatment on the market, known as dulaglutide, still requires a once-weekly injection.
Pricking fingers to draw out blood for testing their blood sugar, is a painful inconvenience that diabetics have to go through, throughout their lifetimes. But, there are many solutions being worked upon to make this process non-invasive. FDA on Wednesday approved the first continuous glucose level monitoring system for adults -- the FreeStyle Libre Flash Glucose Monitoring system works by just inserting a tiny sensor wire below the surface of the skin. This sensor continuously measures and monitors glucose levels. Users can get this data by just waving a wireless mobile reader over the sensor wire.
TORONTO: Scientists have combined radar and artificial intelligence (AI) technologies to detect changes in glucose levels, an advance that may help diabetics monitor their blood sugar without painful finger pricks several times a day. The research involves collaboration with Google and German hardware company Infineon, which jointly developed a small radar device and sought input from select teams around the world on potential applications. Also read: ET's comprehensive diabetes page "We want to sense blood inside the body without actually having to sample any fluid. Our hope is this can be realised as a smartwatch to monitor glucose continuously," said George Shaker, an engineering professor at the University of Waterloo in Canada. The system at Waterloo uses the radar device to send high-frequency radio waves into liquids containing various levels of glucose and receive radio waves that are reflected back to it.